Clinical Trials on Ovarian Serous Cystadenocarcinoma

Total 90856 results

UConn Health

Terminated

Study of Oncoimmunome for the Treatment of Stage III/IV Ovarian Carcinoma

Ovarian Cancer

United States
Mayo Clinic

Terminated

Intra-op Detection of Occult Ovarian Carcinoma Using a Folate-Alpha Receptor Specific Fluorescent Ligand

Ovarian Cancer

United States
National Cancer Institute (NCI)

Completed

A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse)

Ovarian Neoplasm

United States
National Cancer Institute (NCI)

Completed

A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer

Ovarian Neoplasm

United States
Xiaomei Shao
Hangzhou Hospital of Traditional Chinese Medicine

Recruiting

Efficacy of Thumb-tack Needle Treatment for Diminished Ovarian Reserve

Diminished Ovarian Reserve

China
Women's Hospital School Of Medicine Zhejiang University

Not yet recruiting

The Effect of "KB-120" Small Molecular Nutrient in Women With Decreased Ovarian Reserve

Diminished Ovarian Reserve
Tam Anh TP. Ho Chi Minh General Hospital
Abbott

Recruiting

DPOS Versus GnRH Antagonist Protocol for Oocyte Accumulation in Low Ovarian Reserve Patients: An RCT (DPOS)

Diminished Ovarian Reserve

Vietnam
Nanjing University

Recruiting

A Randomized Controlled Study of Different Trigger Modes of Antagonist Regimen in Patients With Low Ovarian Reserve

Poor Ovarian Response

China
Shandong University
The Second Hospital of Hebei Medical University; RenJi Hospital

Not yet recruiting

Effect of Growth Hormone Injection on the IVF/ICSI Outcome of Patients With Poor Ovarian Reserve.

Poor Ovarian Reserve
IVI Bilbao

Recruiting

Influence of PRGF (Plasma Rich in Growth Factors) Puncture in Ovaries With Low Follicular Reservetechniques (PRGFO-2020)

Low Ovarian Reserve

Spain
Ferring Pharmaceuticals

Completed

A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation. (RAINBOW)

Controlled Ovarian Stimulation

United Kingdom, Denmark, Belgium, Czechia, Spain
Ferring Pharmaceuticals

Completed

Study to Assess the Patterns of Use of REKOVELLE® in Naïve Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures (PROFILE)

Controlled Ovarian Stimulation

Australia, Austria, Belgium, Canada, Germany, Italy, Netherlands, Poland, Spain, United Kingdom
ShangHai Ji Ai Genetics & IVF Institute

Completed

the Effect of Transcutaneous Electrical Acupoint Stimulation on the Quality of Oocyte on Poor Ovarian Response(POR) (POR)

Poor Ovarian Response

China
Organon and Co

Completed

Japanese Bridging Trial of Org 37462 (Study P05969)(COMPLETED)

Controlled Ovarian Stimulation
Organon and Co

Completed

A Study to Assess the Efficacy and Safety of Ganirelix (Orgalutran®) Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for in Vitro Fertilization (IVF) or Intra Cytoplasmatic Sperm Injection (ICSI) (Study 38651)(P05703)

Controlled Ovarian Stimulation
Al Baraka Fertility Hospital

Unknown

Novel Therapy for Poor Responders Management

Poor Ovarian Response

Bahrain
Centre Hospitalier Universitaire de Nīmes

Completed

Ovarian Reserve and Embryo Implantation (IRO)

IVF | Ovarian Reserve

France
Shaanxi Hospital of Traditional Chinese Medicine
Northwest Women's and Children's Hospital, Xi'an, Shaanxi

Unknown

A Trial Study on Acupuncture Treatment of Poor Ovarian Response

Poor Ovarian Response

China
Sun Yat-sen University

Unknown

The Effect of Growth Hormone in Assisted Reproductive Technology Clinical Outcome of Poor Responder

Low Ovarian Reserve
GeneScience Pharmaceuticals Co., Ltd.
Peking University People's Hospital; Peking University Third Hospital

Unknown

Effect of Recombinant Human Growth Hormone Injection on the Clinical Outcome of POR in Patients Undergoing IVF/ET

Poor Ovarian Response

China
Johns Hopkins University

Withdrawn

Endometrial Luteal Phase Characteristics and Luteal Phase Support in Controlled Ovarian Stimulation Protocols With GnRH Antagonists:Focusing on MicroRNA

Controlled Ovarian Stimulation

United States
Wake Forest University Health Sciences

Completed

Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) (HOPE)

Unspecified Childhood Solid Tumor, Protocol Specific | Pseudomyxoma Peritonei | Stage IV Ovarian Epithelial Cancer | Stage IV Ovarian Germ Cell Tumor | Ovarian Sarcoma | Recurrent Ovarian Epithelial Cancer | Stage IV Colon Cancer | Recurrent Colon Cancer | Carcinoma of the Appendix | Ovarian Stromal Cancer and other conditions

United States
Georgetown University
United States Department of Defense

Suspended

A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients

Ovarian Cancer Stage IV | Ovarian Cancer Stage III | Ovarian Cancer Stage 3

United States
Mersana Therapeutics
GOG Foundation; European Network of Gynaecological Oncological Trial Groups...

Terminated

Upifitamab Rilsodotin Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer (UP-NEXT) (UP-NEXT)

Fallopian Tube Cancer | Primary Peritoneal Cancer | High Grade Serous Ovarian Cancer

United States, Australia, Canada
Gynaecologisch Oncologisch Centrum Zuid
Amsterdam UMC, location VUmc; The Netherlands Cancer Institute; Leiden University... and other collaborators

Recruiting

CADx - Radiomics to Distinguish the Origin of Ovarian Tumors (CADx)

Ovarian Cancer

Netherlands
Centre Francois Baclesse

Recruiting

Constitution of ex Vivo Ovarian Tumor Models for the Validation of the Interest of Innovative Therapies and the Search for Tumor or Circulating Biomarkers Predictive of Treatment Response (OVAREX)

Ovarian Cancer

France
University of Wisconsin, Madison

Completed

EURAD MRI Classification of US Indeterminate Adnexa Lesions

Ovarian Tumor

United States
Fuda Cancer Hospital, Guangzhou
University of Michigan

Completed

Safety and Effectivity Immunotherapy to Treat Ovarian Cancer With Cancer Stem Cells Vaccine

Neoplasms,Ovarian

China
Centre Francois Baclesse
GRECAN

Completed

Ex Vivo Evaluation of the Interest of the Association of Platinum With a Molecule BH3-mimetic ABT-737 in Samples of Ovarian Tumors (ABT737 exvivo)

Ovarian Cancer

France
Grupo Español de Investigación en Cáncer de Ovario
Roche Pharma AG

Terminated

Neoadjuvant Therapy in Advanced Ovarian Cancer With Avastin (NOVA)

Cancer, Ovarian

Spain
Imperial College London
GlaxoSmithKline

Completed

[18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer (PAZPET-1)

Ovarian Neoplasm

United Kingdom
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian Carcinomas

Ovarian Cancer

Greece
Royal Surrey County Hospital NHS Foundation Trust

Unknown

Minimally Invasive Robotic Surgery, Role in Optimal Debulking Ovarian Cancer, Recovery & Survival (MIRRORS)

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer | Ovarian Neoplasm | Ovarian Neoplasm Epithelial

United Kingdom
Gradalis, Inc.

Completed

Salvage Ovarian FANG™ Vaccine + Carboplatinum

Stage IV Ovarian Cancer | Stage III Ovarian Cancer

United States
Massachusetts General Hospital

Terminated

Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment

Recurrent Ovarian Cancer | Platinum Sensitive Ovarian Cancer

United States
National Cancer Institute (NCI)
Gynecologic Oncology Group

Completed

Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Fallopian Tube Cancer | Stage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer

United States
Peking University Third Hospital

Recruiting

Effect of NMN (Nicotinamide Mononucleotide) on Diminished Ovarian Reserve (Including Premature Ovarian Insufficiency)

Diminished Ovarian Reserve | Premature Ovarian Insufficiency

China
Catholic University of the Sacred Heart

Completed

Surgical Complications Related to Primary or Interval Debulking in Ovarian Neoplasm (SCORPION)

Stage IIIC Ovarian Cancer

Italy
Institut Curie
ARCAGY/ GINECO GROUP

Completed

Study Describing the Coverage, Cares and the Fertility of Patients of Less Than 45 Years With a Borderline Ovarian Tumor (OPTIBOT)

Borderline Ovarian Tumors

France
Cengiz Gokcek Women's and Children's Hospital

Completed

Endocan Levels in Women With Premature Ovarian Insufficiency (Endocan&POI)

Premature Ovarian Failure

Turkey
Sichuan Cancer Hospital and Research Institute

Unknown

Efficacy and Safety of Apatinib As Third Line Therapy in Patients With Advanced Ovarian Cancer

Angiogenesis Inhibitors，Ovarian Neoplasms

China
Etlik Zubeyde Hanim Womens' Health and Teaching...

Completed

Ovarian Hyperstimulation Syndrome and Cabergoline

Ovarian Hyperstimulation Syndrome | Polycystic Ovarian Syndrome
ZIWIG
Monitoring Force Group; iGenSeq

Recruiting

Evaluation of Salivary RNAs in the Presence of an Adnexal Mass of Ovarian Origin (OVAmiARN)

Ovarian Cancer | Ovarian Cyst Benign | Borderline Ovarian Cancer

France
Lei Li

Recruiting

Albumin-bound Paclitaxel and Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer

Recurrent Ovarian Carcinoma | Platinum-resistant Ovarian Cancer | Bevacizumab | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Albumin-bound Paclitaxel

China
National Cancer Institute (NCI)

Completed

3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer

Stage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer

United States
Duke University

Completed

Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy

Ovarian Cancer | Venous Thromboembolism

United States
Stanford University

Completed

Comparison of Transdermal and Oral Estrogens in Adolescent Girls With Ovarian Failure

Ovarian Failure, Premature

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer

Ovarian Carcinoma

United States
Nuvectis Pharma, Inc.
GOG Foundation; European Network of Gynaecological Oncological Trial Groups...

Recruiting

A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer

Ovarian Cancer | Ovarian Endometrioid Adenocarcinoma | Advanced Solid Tumor | Ovarian Clear Cell Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Clear Cell Tumor | Ovarian Endometrioid Tumor | ARID1A Gene Mutation

United States, United Kingdom
Stanford University

Terminated

Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer

Stage IV Ovarian Epithelial Cancer | Stage IV Ovarian Germ Cell Tumor | Recurrent Ovarian Epithelial Cancer | Recurrent Ovarian Germ Cell Tumor | Malignant Tumor of Peritoneum

United States

Clinical Trials on Ovarian Serous Cystadenocarcinoma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations